IL33 and respiratory system disorder: Future studies should prioritize investigating undiscovered pathways of IL-33 production and action, assessing drug efficacy and safety, and exploring patient benefits to advance our understanding and clinical management of respiratory diseases associated with type 2 inflammation Table 1.